The Food and Drug Administration recently approved gene therapy to treat sickle cell disease among children ages 2 and older, which a Nashville doctor described as a medical milestone.

A new treatment for children aged 2 or older with sickle cell disease has been approved by the U.S. Food & Drug ...

Cece Calhoun ’21, medical director of Yale’s Sickle Cell Program, reflects on the challenges of building teams and structures ...

Sickle cell disease (SCD) is a group of genetic blood disorders. A person inherits SCD from their parents when they inherit two copies of the sickle cell gene, one from each parent. This hereditary ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. The Centers for Medicare and Medicaid Services announced in July ...

Sickle cell disease (SCD) can affect people of any ethnicity but is much more common among Africans and African Americans. Other ethnic groups with higher rates of SCD include Hispanic Americans from ...

Ibemere, also a Duke Global Health Institute faculty member, set out to change that. She began organizing intensive boot ...

Daniel Cressy has suffered from symptoms of the painful genetic condition since birth ...

Sickle cell disease can cause various eye-related complications, including retinopathy. If untreated, sickle cell retinopathy can cause permanent vision loss. Treatments include laser therapy and eye ...

On World Sickle Cell Day, a visit to Ward 16 reveals the daily reality of children and adolescents battling pain, long queues ...